Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients

Aberrant Promoter Methylation of Sparc in Ovarian Cancer

(2015) Matthew J. Socha et al.   NEOPLASIA

Identification of High-Risk Stage II Colorectal Tumors by Combined Analysis of the NDRG1 Gene Expression and the Depth of Tumor Invasion

(2009) Barbara Strzelczyk et al.   ANNALS OF SURGICAL ONCOLOGY

Triple negative breast cancers: Clinical and prognostic implications

(2009) S.J. Dawson et al.   EUROPEAN JOURNAL OF CANCER

Metastasis-related Plasma Membrane Proteins of Human Breast Cancer Cells Identified by Comparative Quantitative Mass Spectrometry

(2009) Rikke Leth-Larsen et al.   MOLECULAR & CELLULAR PROTEOMICS

SPARC: a matricellular regulator of tumorigenesis

(2009) Shanna A. Arnold et al.   Journal of Cell Communication and Signaling

SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2′deoxycytidine to increase SPARC expression and improve therapy response

(2008) S Cheetham et al.   BRITISH JOURNAL OF CANCER

Cancer Statistics, 2008

(2008) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host

(2008) Osvaldo L. Podhajcer et al.   CANCER AND METASTASIS REVIEWS

Epithelial-Mesenchymal Transition in Breast Cancer Relates to the Basal-like Phenotype

(2008) D. Sarrio et al.   CANCER RESEARCH

Association of an Extracellular Matrix Gene Cluster with Breast Cancer Prognosis and Endocrine Therapy Response

(2008) J. Helleman et al.   CLINICAL CANCER RESEARCH

SPARC-induced increase in glioma matrix and decrease in vascularity are associated with reduced VEGF expression and secretion

(2008) Christopher K. Yunker et al.   INTERNATIONAL JOURNAL OF CANCER

The fibromatosis signature defines a robust stromal response in breast carcinoma

(2008) Andrew H Beck et al.   LABORATORY INVESTIGATION